Rule 54 of the Patents Rules, 2003
Omitted provision
Rule 54 closed the Exclusive Marketing Rights chapter of the Patents Rules and was omitted when that chapter was repealed in the 2005 reforms.
Official legal text
An omitted provision keeps its slot in the statute. The alternative, renumbering everything that follows, would make older judgments and office records hard to follow. The number therefore survives as a marker, and readers tracing historical documents still need an explanation of what once stood here.
Read this as a plain-language summary. If it and the official text, or a relevant Gazette notification, say different things, the official text and the notification are what count.
What this rule requires, step by step
Rule 54 was the final rule of Chapter V of the Patents Rules, 2003. With the five rules before it, it supported the Exclusive Marketing Rights sections that the Patents (Amendment) Act, 1999 had inserted into the Patents Act, 1970. Those sections let the Controller grant a company the exclusive right to sell a medicine or agricultural chemical in India for a limited period, during the years when patents for such products were not yet available here. The whole chapter went when the Patents (Amendment) Act, 2005 deleted the parent sections and India opened product patents from 1 January 2005.
One important consequence of that switch does survive, and readers often confuse it with the old marketing right. Where a business had already made a significant investment and was producing and marketing a product covered by a stored pre-2005 application, the Act protects it from infringement proceedings once the patent is granted, provided it pays a reasonable royalty to the patentee. That protection sits in the publication section of the Act, not in Chapter V, and it is the only lasting trace of the transition that a modern business is likely to meet. Rule 54 itself has no continuing effect.
Why this rule matters
Businesses that were already selling a product before 2005 that a later granted patent covers, and their advisers.
Only when a very old application, with a pre-2005 priority, matures into a granted patent that touches an existing product line.
Nothing itself; the surviving protection for pre-2005 investment comes from the publication section of the Act.
Ignoring the rule costs nothing, but confusing it with the surviving royalty protection can lead a business to claim a defence it does not have.
How it works in practice
A pre-2005 product line meets a late-granted patent
Ghatkopar Polymers has been making a specialised crop protection formulation since 2001. Years later it receives a notice saying an Indian patent has been granted on the compound, from an application filed in the 1990s and held without examination during the transition years. The company's first instinct is to argue that the applicant once had only an exclusive marketing right, which has long expired. Its adviser corrects the approach. The old Chapter V rules, ending with Rule 54, were removed in 2005 and cannot help. The right argument, if the facts support it, is the statutory protection for a person who had made significant investment and was producing and marketing the product before 1 January 2005, which allows continued production against payment of a reasonable royalty. The adviser asks for invoices, plant records and audited accounts from before that date, because the defence depends entirely on proving the investment and the sales, not on the repealed chapter.
Simplified illustration only. Actual legal outcomes depend on the facts.
Key points to remember
- Rule 54 was the last rule of the Exclusive Marketing Rights chapter of the Patents Rules, 2003.
- The chapter was omitted when the Patents (Amendment) Act, 2005 repealed the parent sections.
- A separate protection for pre-2005 investment in stored applications still exists in the Act.
- That protection allows continued production against a reasonable royalty, and it must be proved with records.
Connected provisions
Because this page covers a rule rather than a section, the related Act provisions are shown in their own list. The section tells you what the law requires. The rule, explained above, tells you how the Patent Office expects that requirement to be met.
Forms, deadlines and fees
Fees are prescribed in the First Schedule to the Patents Rules. Because the Schedule is revised from time to time, and charges different amounts to different categories of applicant and for physical as against electronic filing, this page describes the fee without stating a figure. How Indian patent fees work.
Related judgments
No judgment summaries appear here yet. Our process requires a legal review of each case note before publication, covering the citation, the court and the point actually decided. Until a note for this provision has passed that check, the section stays empty rather than carrying unverified material. How case notes are prepared.
Questions people ask about Rule 54
I have been selling a product since before 2005 and a new patent covers it. What now?
The Act contains a specific protection for businesses that had made a significant investment and were producing and marketing a product before 1 January 2005, where the patent later granted comes from an application held during the transition. Such a business cannot be sued for infringement but must pay the patentee a reasonable royalty. Whether it applies depends on documentary proof of the investment and sales before that date, so gather invoices, accounts and plant records early and take specific advice.
Did Exclusive Marketing Rights turn into patents automatically?
No. An Exclusive Marketing Right was never converted into a patent. It simply ended, either when its own period ran out or when the related application was decided. The application behind it still had to be examined on its merits after 2005 and could be refused, opposed or granted with narrowed claims. Many transition-era applications were opposed successfully. The existence of an old marketing right tells you nothing about whether a valid patent exists today.
Facing a patent on a product you already sell?
MYCrave Consultancy assesses your position, including transition-era defences, before you respond to any notice.
You will be speaking with MYCrave Consultancy & Services, the firm that operates this platform. General questions are answered free; matter‑specific work is quoted before anything is done.